Form S-1/A Apnimed, Inc.
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260727/AK22GG2FZC2RMZZU222D2ZYKCBILEZ22Z282
Filed on: July 27, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- OFA Group announces 1-for-10 reverse stock split effective July 31
- FDA grants priority review for Pfizer's Talzenna and Xtandi combo in prostate cancer
- Nth Cycle to go public via SPAC deal at $585 million valuation
Create E-mail Alert Related Categories
SEC FilingsRelated Entities
S1Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
